{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T16:16:39Z","timestamp":1679588199237},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1007\/bf01081513","type":"journal-article","created":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T08:23:28Z","timestamp":1107246208000},"page":"201-206","source":"Crossref","is-referenced-by-count":5,"title":["Indium-111 octreotide scintigraphy in neurofibromatosis"],"prefix":"10.1007","volume":"22","author":[{"given":"Carlo L.","family":"Maini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele R.","family":"Cioffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Tofani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Sciuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine M.","family":"Carapella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Crecco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/edrv-12-4-450","volume":"12","author":"SWJ Lamberts","year":"1991","unstructured":"Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and. its analogs in the diagnosis and treatment of tumors.Endocr Rev 1991; 12: 450?482.","journal-title":"Endocr Rev"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","volume":"20","author":"EP Krenning","year":"1993","unstructured":"Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WAR, Kooij PPM, Oei HY, van Hagen M, Postema PTE, de Jong M, Reubi JC, Visser TJ, Reijs AEM, Hofland LJ, Koper JW, Lamberts SWJ. Somatostatin receptor scintigraphy with (111In-DTPA-D-Phe)- and (123I-Tyr)-octreotide: the Rotterdam experience with more than 1000 patients.Eur J Nucl Med 1993;20:716?731.","journal-title":"Eur J Nucl Med"},{"key":"CR3","first-page":"505","volume":"14","author":"CL Maini","year":"1993","unstructured":"Maini CL, Tofani A, Sciuto R, Carapella C, Cioffi R, Crecco M. Scintigraphy visualization of somatostatin receptors in human meningiomas using 111-indium-DTPA-D-Phe-l-octreotide.Nucl Med Commun 1993; 14: 505?558.","journal-title":"Nucl Med Commun"},{"key":"CR4","first-page":"59","volume":"27","author":"K Scheidhauer","year":"1993","unstructured":"Scheidhauer K, Hildebrandt G, Luyken C, Schomacker K, Klung N, Schicha H. Somatostatin receptor scintigraphy in brain tumors and pituitary tumors: first experiences.Hormone Metab Res [Suppl] 1993; 27: 59?62.","journal-title":"Hormone Metab Res"},{"key":"CR5","first-page":"359","volume":"38","author":"A Tofani","year":"1994","unstructured":"Tofani A, Sciuto R, Scelsa MG, Semprebene A, Cucchi R, Maini CL. In vivo tumor imaging of somatostatin receptors by 111-In-octreotide: a two-year experience.J Nucl Biol Med 1994;38:359.","journal-title":"J Nucl Biol Med"},{"key":"CR6","first-page":"5758","volume":"47","author":"JC Reubi","year":"1987","unstructured":"Reubi JC, Lang W, Maurer R, Koper JW, Lamberts SWJ. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system.Cancer Res 1987: 47: 5758?5764.","journal-title":"Cancer Res"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","volume":"45","author":"National Institute of Health Consensus Development Conference","year":"1988","unstructured":"National Institute of Health Consensus Development Conference. Neurofibromatosis. Conference Statement.Arch Neurol 1988;45:575?578.","journal-title":"Arch Neurol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/00004728-198507010-00006","volume":"9","author":"GM Bydder","year":"1985","unstructured":"Bydder GM, Kingsley PE, Brown J, Wiendorf HP, Young IR. MR imaging of meningiomas including studies with and without gadolinium-DTPA. J Comput Assist Tomogr 1985; 9: 690?697.","journal-title":"J Comput Assist Tomogr"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/978-3-642-72568-5","volume-title":"Magnetic resonance imaging of central nervous system disease","author":"WJ Huk","year":"1990","unstructured":"Huk WJ, Gademann G, Friedmann G.Magnetic resonance imaging of central nervous system disease. Berlin Heidelberg New York: Springer; 1990: 401?403."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/0024-3205(91)90052-D","volume":"49","author":"WH Bakker","year":"1991","unstructured":"Bakker WH, Alberts R, Bruns C, Breeman WAP, Hofland LJ, Marbach P, Pless J, Pralet D, Stolz B, Koper JW, Lamberts SWJ, Visser TJ, Krenning EP (111-In-DTPA-D-PHE)-Octreotide, a potential radiopharmaceutical for imaging of Somatostatin receptor-positive tumours: synthesis, radiolabelling and in vitro validation.Life Sci 1991; 49: 1583?1591.","journal-title":"Life Sci"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1210\/jcem-63-2-433","volume":"63","author":"JC Reubi","year":"1986","unstructured":"Reubi JC, Maurer R, Klijn JGM, Stefanko SZ, Foekens JA, Blaauw G, Blankestein MA, Lamberts SWJ. High incidence of somatostatin receptors in human meningiomas: biochemical charaterization.J Clin Endocrinol Metab 1986; 63: 433?438.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01081513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01081513\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01081513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T05:25:53Z","timestamp":1556342753000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01081513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["BF01081513"],"URL":"https:\/\/doi.org\/10.1007\/bf01081513","relation":{},"ISSN":["0340-6997","1619-7089"],"issn-type":[{"value":"0340-6997","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}